Vessey Rupert's Form 4 filing
Bristol Myers Squibb Co (BMY) · filed May 4, 2023
- Accession no.
- 0000014272-23-000114
- Filed
- May 4, 2023
- Trade date
- May 3, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $3.38M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vessey RupertCIK 0001677618 | Officer (EVP & President, Research) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 3, 2023 | Common Stock, $0.10 par value | SSaleDisposed | −50,385 | $67.06 | −$3,378,818.1 | 47,751 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.